A retrospective study analysing efficacy of GLP-1 Agonist as a add on therapy to Insulin therapy in Type 2 Diabetes
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Dulaglutide (Primary) ; Liraglutide (Primary) ; Semaglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association